Why State-Specific Compliance Matters

Prescription medication laws vary dramatically across the United States, and non-compliance can result in license suspension, fines, or criminal charges.

While federal agencies (DEA and FDA) set baseline requirements, each state maintains its own Board of Pharmacy with unique regulations governing prescribing authority, dispensing requirements, record-keeping, and controlled substance monitoring programs (PDMPs).

This hub page covers federal law and links to detailed state-specific guides. Click your state on the interactive map below or select from the list.

Select Your State for Specific Requirements

AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY

Can't find your state? Use the list below the map.

Click on any state to view detailed prescribing and dispensing requirements

Federal Law: DEA & FDA Requirements

DEA (Drug Enforcement Administration)

The DEA regulates controlled substances under the Controlled Substances Act (CSA), classifying drugs into Schedules I-V based on abuse potential and medical use.

Schedule II: Highest potential for abuse with accepted medical use (controlled substances). No refills allowed.
Schedule III-V: Lower abuse potential. Limited refills (III-IV: up to 5 refills within 6 months).
DEA Registration: Required for all prescribers and dispensers handling controlled substances.
Record-Keeping: Prescribers must maintain records for 2 years; pharmacies for 2-3 years depending on state.
Electronic Prescriptions (EPCS): Required in many states for Schedule II-V controlled substances.

FDA (Food and Drug Administration)

The FDA oversees drug approval, labeling, safety monitoring (MedWatch), and REMS (Risk Evaluation and Mitigation Strategies) programs.

Drug Approval: All prescription medications must be FDA-approved before marketing.
REMS Programs: Required for high-risk medications (e.g., isotretinoin, clozapine). Prescribers must register and complete training.
Adverse Event Reporting: Healthcare providers should report serious adverse events via MedWatch.
Off-Label Use: Legal but requires informed consent and documentation.

Have a compliance question?

PDMP requirements, prescribing limits, drug regulations — get the answer in seconds, cited to statute.

Try Free Compliance Tool

Key Compliance Topics Across All States

Prescription Drug Monitoring Programs (PDMPs)

Nearly all states require prescribers to check PDMPs before prescribing controlled substances. Check your state for specific query timeframes and exemptions.

Telemedicine Prescribing

State requirements vary for establishing patient relationships, prescribing controlled substances, and out-of-state licensure. Ryan Haight Act restricts Schedule II-V telemedicine prescribing without in-person exam (federal).

Collaborative Practice Agreements

Many states allow pharmacists to prescribe under collaborative practice agreements (CPAs) with physicians. Scope varies by state.

Controlled Substance Limits

Many states impose day-supply limits for initial controlled substance prescriptions (typically 3-7 days). Check your state for specifics.

Naloxone Co-Prescribing Requirements

Some states require or recommend prescribing overdose reversal agents alongside controlled substances for high-risk patients.

Stop Searching. Start Prescribing with Confidence.

RX Agent gives you instant, state-specific compliance answers so you can focus on patient care instead of regulatory research.